liraglutide versus tirzepatide vs semaglutide and for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States Side effects associated with liraglutide,

A 2020 study in Scientific Reports noted a similar result and found that women were more likely to experience headaches and dizziness

The dose-response curve is worth paying attention to, as most people plateau well below the maximum dose when lifestyle fundamentals are in place How Tirzepatide Works: Dual GIP/GLP-1 Receptor Mechanism Tirzepatide is a dual receptor agonist designed to simultaneously activate the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), which makes its mechanism fundamentally different from any drug on the market solely targeting GLP-1R

Want the highest weight loss potential backed by clinical results

These medications are not a replacement for healthy habits, but they may make those habits easier to follow by reducing appetite pressure